11:39 AM EST, 11/05/2025 (MT Newswires) -- (Updates with the latest stock movement in the first paragraph and headline.)

Zimmer Biomet ( ZBH ) shares were down nearly 16% in recent Wednesday trading after the company reported Q3 revenue that missed analyst estimates.

The company reported Q3 adjusted earnings Wednesday of $1.90 per diluted share, up from $1.74 a year earlier.

Analysts polled by FactSet expected $1.87.

Revenue for the quarter ended Sept. 30 was $2.00 billion, up from $1.82 billion a year earlier.

Analysts surveyed by FactSet expected $2.01 billion.

For 2025, the company maintained its previous expected adjusted EPS of $8.10 to $8.30 and revenue growth of 6.7% to 7.7%.

Analysts polled by FactSet expect non-GAAP EPS of $8.16.

Price: 86.41, Change: -16.78, Percent Change: -16.26